ASSOCIATION OF ANTHROPOMETRIC AND LIFESTYLE FACTORS WITH PROSTATE SPECIFIC ANTIGEN (PSA) TRAJECTORIES IN MEN WITH LOCALISED PROSTATE CANCER UNDERGOING ACTIVE MONITORING

ASSOCIATION OF ANTHROPOMETRIC AND LIFESTYLE FACTORS WITH PROSTATE SPECIFIC ANTIGEN (PSA) TRAJECTORIES IN MEN WITH LOCALISED PROSTATE CANCER UNDERGOING ACTIVE MONITORING

Detalhes bibliográficos
Main Authors:	Burton, A, Martin, R, Holly, J, Hamdy, F, Neal, D, Donovan, J, Tilling, K
Formato:	Journal article
Publicado em:	2011

Registos relacionados

Associations of lifestyle factors and anthropometric measures with repeat PSA levels during active surveillance/monitoring.
Por: Burton, A, et al.
Publicado em: (2012)

Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: the ProtecT study.
Por: Burton, A, et al.
Publicado em: (2013)

Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts.
Por: Tilling, K, et al.
Publicado em: (2010)

Investigating the prostate specific antigen, body mass index and age relationship: is an age-BMI-adjusted PSA model clinically useful?
Por: Harrison, S, et al.
Publicado em: (2016)

Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study.
Por: Catto, J, et al.
Publicado em: (2011)

Suitability of PSA-detected localised prostate cancers for focal therapy: Experience from the ProtecT study
Por: Catto, J, et al.
Publicado em: (2011)

Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
Por: Young, GJ, et al.
Publicado em: (2017)

Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis.
Por: Roddam, A, et al.
Publicado em: (2005)

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
Por: Collin, S, et al.
Publicado em: (2009)

Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial
Por: Wade, J, et al.
Publicado em: (2015)

THE PROTECT TRIAL - EVALUATING THE EFFECTIVENESS OF TREATMENTS FOR CLINICALLY LOCALISED PROSTATE CANCER
Por: Lane, J, et al.
Publicado em: (2009)

The protecT (prostate testing for cancer and treatment) study: Evaluating screening and treatment of clinically localised prostate cancer in the UK
Por: Hamdy, F, et al.
Publicado em: (2006)

Metabolic imbalance and prostate cancer progression.
Por: Burton, A, et al.
Publicado em: (2010)

Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level.
Por: Törnblom, M, et al.
Publicado em: (2001)

Prostate-specific antigen (PSA) and distress: - a cross-sectional nationwide survey in men with prostate cancer in Sweden
Por: Ulrika Rönningås, et al.
Publicado em: (2019-07-01)

Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA.
Por: Sävblom, C, et al.
Publicado em: (2009)

Prostate Specific Antigen (PSA): The Historical Perspective
Por: T. Ming Chu
Publicado em: (2020-12-01)

Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer
Por: Amit M. Algotar PhD, MBBS, et al.
Publicado em: (2011-05-01)

The ProtecT trial - Evaluating the effectiveness of treatment for clinically localised prostate cancer (ISRCTN20141297)
Por: Lane, J, et al.
Publicado em: (2004)

Uji diagnostik prostate spesific antigen (PSA) pada keganasan prostat
Por: , DAHESIHDEWI, Andaru, et al.
Publicado em: (2002)

Role of Prostate-Specific Antigen (PSA) in Patients with Benign Prostate Hyperplasia
Por: Priya Duvedi, et al.
Publicado em: (2019-05-01)

Experiences and decision processes during PSA testing and prostate biopsy: A qualitative study
Por: Avery, K, et al.
Publicado em: (2007)

Lifestyle factors and prostate-specific antigen (PSA) testing in UK Biobank: Implications for epidemiological research
Por: Littlejohns, T, et al.
Publicado em: (2016)

Does prostate-specific antigen (PSA) mass or free PSA mass improve the accuracy of predicting total prostate volume in relation to obesity in men with biopsy-proven benign prostatic hyperplasia?
Por: Jin-Woo Jung, et al.
Publicado em: (2019-01-01)

Serum insulin-like growth factor-I is positively associated with serum prostate-specific antigen in middle-aged men without evidence of prostate cancer.
Por: Oliver, SE, et al.
Publicado em: (2004)

PSA testing for men at average risk of prostate cancer
Por: Bruce K Armstrong, et al.
Publicado em: (2017-07-01)

Development, validation and evaluation of an instrument for active monitoring of men with clinically localised prostate cancer: systematic review, cohort studies and qualitative study
Por: Andrew J Simpkin, et al.
Publicado em: (2015-07-01)

Alcohol consumption and PSA-detected prostate cancer risk--a case-control nested in the ProtecT study.
Por: Zuccolo, L, et al.
Publicado em: (2013)

The protect trial - Evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies
Por: Lane, J, et al.
Publicado em: (2007)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
Por: Harrison, S, et al.
Publicado em: (2020)

Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.
Por: Oliver, SE, et al.
Publicado em: (2004)

Longitudinal prostate-specific antigen reference ranges: Choosing the underlying model of age-related changes
Por: Simpkin, A, et al.
Publicado em: (2013)

Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?
Por: Avery, K, et al.
Publicado em: (2008)

Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA committee.
Por: Blijenberg, BG, et al.
Publicado em: (2003)

Seasonal variation in prostate-specific antigen levels: A large cross-sectional study of men in the UK
Por: Down, L, et al.
Publicado em: (2011)

Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK.
Por: Down, L, et al.
Publicado em: (2011)

Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: The ProtecT three-arm RCT
Por: Hamdy, FC, et al.
Publicado em: (2020)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
Por: Rosario, D, et al.
Publicado em: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.
Por: Rosario, D, et al.
Publicado em: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: Prospective evaluation within ProtecT study
Por: Rosario, D, et al.
Publicado em: (2012)